Definitive Contract 75F40126C00217

The Food and Drug Administration awarded a $2,131,932 definitive contract to Emergency Care Research Institute (Ecri) for advanced research and development of regulatory science on September 30, 2026, under firm fixed-price terms with no set-aside.

Place of performance is Doylestown, PA. The originating BAA (CDRH135512) addresses regulatory science capability development aligned with the Center for Devices and Radiological Health's mission. The contract runs through September 30, 2030.

Emergency Care Research Institute is a nonprofit healthcare research organization that serves federal agencies as a prime contractor, delivering medical device evaluations, evidence synthesis, and clinical evidence assessment services. The vendor maintains the Universal Medical Device Nomenclature System (UMDNS) vocabulary under a sole-source contract with the National Library of Medicine and conducts systematic reviews and technology assessments for the Agency for Healthcare Research and Quality under its Evidence-based Practice Centers program. Ecri competes in full-and-open procurements across civilian healthcare, defense health, and veterans' health customer bases without SBA certifications. SCI-reported invoicing on federal service contracts shows median government-paid rates around $147.46/hr, with senior labor pricing through $543.07/hr. Ecri performs work primarily at its Plymouth Meeting headquarters with subordinate delivery locations in Doylestown, Prescott Arizona, Vancouver Washington, Frederick Maryland, and Bethesda.